Literature DB >> 11286545

A case of X-linked agammaglobulinemia diagnosed in adulthood.

D M Stewart1, L Tian, D L Nelson.   

Abstract

X-linked agammaglobulinemia (XLA), caused by mutations in Bruton's tyrosine kinase (BTK), typically presents in early childhood. We report here the case of a male diagnosed at age 23 years with hypogammaglobulinemia, originally classified as common variable immunodeficiency (CVID). On further analysis at age 40, flow cytometric analysis of lymphocytes showed only 0.1% B cells and Western blot analysis showed a deficiency of BTK protein in peripheral blood mononuclear cells, indicating the patient has XLA. BTK cDNA and genomic DNA analysis revealed a splice site mutation at the 3' end of intron 13. Multiple abnormally spliced mRNA species were identified, one of which was predicted to produce a protein with a 24-amino-acid insertion between the SH2 and kinase domains. In vitro kinase assay of this product showed weak kinase activity, perhaps resulting in milder than usual disease. XLA can present in adult males, and sporadic cases may be misdiagnosed as CVID. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286545     DOI: 10.1006/clim.2001.5024

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease.

Authors:  M E Conley; D M Farmer; A K Dobbs; V Howard; Y Aiba; S A Shurtleff; T Kurosaki
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

3.  X-linked agammaglobulinemia diagnosed in adulthood: a case report.

Authors:  Takeki Mitsui; Norifumi Tsukamoto; Hirokazu Kanegane; Kazunaga Agematsu; Tomomi Sekigami; Hiroyuki Irisawa; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Takafumi Matsushima; Masamitsu Karasawa; Hirokazu Murakami; Toshio Miyawaki; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

Review 4.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

5.  Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients.

Authors:  Eun-Kyeong Jo; Yue Wang; Hirokazu Kanegane; Takeshi Futatani; Chang-Hwa Song; Jeong-Kyu Park; Jung Soo Kim; Dong Soo Kim; Kang-Mo Ahn; Sang-Il Lee; Hyeon Jin Park; Youn Soo Hahn; Jae-Ho Lee; Toshio Miyawaki
Journal:  J Hum Genet       Date:  2003-05-24       Impact factor: 3.172

6.  Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient.

Authors:  Lee-Moay Lim; Jer-Ming Chang; I-Fang Wang; Wei-Chiao Chang; Daw-Yang Hwang; Hung-Chun Chen
Journal:  BMC Pediatr       Date:  2013-09-27       Impact factor: 2.125

7.  A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases.

Authors:  Tábata T França; Luiz F B Leite; Tiago A Maximo; Christiane G Lambert; Nuria B Zurro; Wilma C N Forte; Antonio Condino-Neto
Journal:  Front Pediatr       Date:  2018-05-04       Impact factor: 3.418

8.  X-linked agammaglobulinemia diagnosed late in life: case report and review of the literature.

Authors:  Justin R Sigmon; Ehab Kasasbeh; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2008-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.